BioPharma Today: MannKind's Uphill Climb to Partner Inhaled Insulin

J.P. Morgan, MannKind's plans to partner inhaled insulin are on hold until the Food & Drug Administration completes its review of the pending application for Afresa. And Wall Street analysts have some advice for investors who... [read full story]                    

powered by
Add Comment
There are also 1 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies